5G Mobile Phone Technology and the Risk of Skin Cancer: A Risk Assessment by the SEAWave Consortium.
Abstract
To meet the ever-growing demands of wireless communication and enable new applications, the 5th generation (5G) New Radio (NR) cellular system was developed to offer better connectivity, to reduce latency, and enable higher data transfer rates. The use of the 5G frequency spectrum is divided into two frequency ranges, Frequency Range 1 (5G NR FR1) from 0.41 GHz to 7.125 GHz, operating in the same frequency range as the 2G-4G cellular systems and WLAN systems, and Frequency Range 2 (5G NR FR2) from 24.25 to 52.60 GHz using millimetre waves (mmWaves) to enable fast transfer of large amounts of data. Since 2019, FR1 has been rapidly deployed in Europe. Until today, in Europe, FR2 has very limited applications. The objective of SEAWave project was to conduct two risk assessments, one for FR1 and one for FR2. Risk assessment procedure included evaluation of evidence of an association between skin cancer and exposure to FR1 and FR2 radiofrequency electromagnetic field (RF-EMF), with the skin being the most exposed organ during use. Both assessments are based on: a comprehensive review of the scientific literature available before the end of the project and the consolidated findings from research studies generated within the SEAWave project. Experiments conducted within SEAWave project included: (i) In vivo experiments on Carcinogenesis-susceptible (Car-S) mice and Patched heterozygous knockout mice (Ptch1 +/-) to investigate the effects of prolonged exposure to 5G FR2 RF-EMF at 27.5 GHz on the development of squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), two of the most common skin tumours. In addition, skin inflammation and nociceptive signalling were analysed in dorsal skin samples taken from mice after early stage whole-body exposure in the first 21 days of postnatal life and after 100 days and 6 months of exposure; (ii) Clinical trial where participants' inner arms were exposed to 5G FR2 RF-EMF at 27.5 GHz to study transcriptomic changes in skin samples induced by 5G FR2 RF-EMF exposure, with particular attention to inflammatory processes; (iii) In vitro experiments using different primary human skin cell lines, that is, light-pigmented primary epidermal juvenile and adult keratinocytes (NHEK-f.c. and NHEK-c.) and light-pigmented primary epidermal adult melanocytes (NHEM) exposed to 5G FR2 RF-EMF at 27.5 GHz to study several endpoints including genotoxicity, aneugenicity, telomere measurement, DNA methylation and transcriptomics. The overall evidence for an association between skin cancer and 5G FR1 has been classified as 'inconclusive' based on the evaluations of human evidence, evidence from animal studies and mechanistic studies classified as 'inadequate'. 5G FR1 evaluations were mainly based on literature review. The overall evidence for an association between skin cancer and 5G FR2 has been classified as 'inconclusive' based on the evaluations of human evidence, and evidence from animal studies and mechanistic studies classified as 'inadequate'. 5G FR2 evaluations were mainly based on findings from the SEAWave project. All classifications were unanimous except for the 5G FR2 mechanistic evidence which a minority considered 'limited'; even with limited evidence the overall assessment for 5G FR2 would have remained 'inconclusive'. An impact evaluation completes the risk assessment, as for inconclusive evidence no quantitative risk assessment could be carried out.
AI evidence extraction
Outcomes measured
- skin cancer incidence
- genotoxicity
- transcriptomics
- inflammation
- nociception
Limitations
- limited FR2 deployment in Europe
- heterogeneous evidence base
- minority view of 'limited' mechanistic evidence for FR2
Suggested hubs
- 5g-policy (0.7)Mapped from the finder screen onto an existing hub.
View raw extracted JSON
{
"study_type": "risk assessment; systematic review; in vivo; in vitro; clinical trial",
"exposure": "RF 100–1000 MHz",
"population": "human skin cells; Car-S and Ptch1+/- mice; human participants",
"sample_size": "multiple cell lines; two mouse strains; clinical trial participants (exact n not stated)",
"outcomes": [
"skin cancer incidence",
"genotoxicity",
"transcriptomics",
"inflammation",
"nociception"
],
"findings": "Overall evidence for skin cancer association with both FR1 and FR2 classified as 'inconclusive' due to inadequate human, animal, and mechanistic data.",
"effect_direction": "unclear",
"limitations": [
"limited FR2 deployment in Europe",
"heterogeneous evidence base",
"minority view of 'limited' mechanistic evidence for FR2"
],
"evidence_strength": "inconclusive",
"peer_review_likelihood": "high",
"keywords": [
"radiofrequency electromagnetic field",
"mobile phone technology",
"squamous cell carcinoma",
"wireless communication",
"electromagnetic field",
"skin cancer incidence",
"whole body exposure",
"frequency spectrum",
"prolonged exposure",
"literature review",
"cancer incidence",
"millimetre waves",
"DNA methylation",
"electromagnetic",
"millimetre wave",
"RF-EMF exposure",
"risk assessment",
"risk assessment)",
"transcriptomics",
"5th generation",
"animal studies",
"carcinogenesis",
"clinical trial",
"radiofrequency",
"mmWave",
"SEAWave",
"skin cancer",
"genotoxicity",
"inflammation",
"nociception"
],
"suggested_hubs": [
{
"slug": "5g-policy",
"weight": "0.7",
"reason": "Mapped from the finder screen onto an existing hub."
}
],
"topic_tags": [
"radiofrequency electromagnetic field",
"mobile phone technology",
"squamous cell carcinoma",
"wireless communication",
"electromagnetic field",
"skin cancer incidence",
"whole body exposure",
"frequency spectrum",
"prolonged exposure",
"literature review",
"cancer incidence",
"millimetre waves",
"DNA methylation",
"electromagnetic",
"millimetre wave",
"RF-EMF exposure",
"risk assessment",
"risk assessment)",
"transcriptomics",
"5th generation",
"animal studies",
"carcinogenesis",
"clinical trial",
"radiofrequency"
]
}AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.
NNEMF synthesis
1. What they did: The SEAWave consortium assessed 5G New Radio in two bands: Frequency Range 1, 0.41 to 7.125 gigahertz, and Frequency Range 2, 24.25 to 52.60 gigahertz millimetre waves. Frequency Range 1 work was mainly a literature review. Frequency Range 2 work added project experiments at 27.5 gigahertz. Mice bred to be susceptible to tumours, and Patched heterozygous knockout mice, received prolonged exposure; dorsal skin was sampled after whole-body exposure in the first 21 days of postnatal life and after 100 days and 6 months, for inflammation and nociceptive signalling, the nerve signals tied to pain. In a clinical exposure, participants' inner arms received 27.5 gigahertz, and skin was read for transcriptomic change, meaning which genes were active, with attention to inflammatory processes. Separate dishes of light-pigmented primary epidermal juvenile and adult keratinocytes, the main surface skin cells, and adult melanocytes, the pigment cells, received 27.5 gigahertz and were assayed for genotoxicity, aneugenicity, telomere length, DNA methylation, and transcriptomics. 2. What they found: Overall evidence for Frequency Range 1 was classified as inconclusive, and the human, animal, and mechanistic evaluations were classified as inadequate. Overall evidence for Frequency Range 2 was also classified as inconclusive, with those same three evaluations classified as inadequate. Every classification was unanimous except the Frequency Range 2 mechanistic evaluation, which a minority considered limited; even with that limited rating the overall Frequency Range 2 assessment would have remained inconclusive. Because the evidence was inconclusive, no quantitative assessment was carried out. 3. How it connects: The shared measurement is millimetre-wave energy meeting skin, read through inflammatory signalling, gene activity, and marks of DNA regulation. Juvenile versus adult keratinocytes, and sampling in the first 21 days of life, are different receiving machinery and reserve, the density-gated part of the response: the same field is applied to cells that are not in the same state. "5G technology: Why should we expect a shift from RF-induced brain cancers to skin cancers?" That paper examined higher radio frequencies meeting skin rather than deeper tissue. "Human Electromagnetic Field Exposure in 5G at 28 GHz." That paper measured human electromagnetic-field exposure in a 5G system near 28 gigahertz, including downlink and uplink. "Assessment of Human Exposure Levels Due to Mobile Phone Antennas in 5G Networks." That paper calculated exposure from a 27 gigahertz phone antenna using skin models of different detail. "Health Council of the Netherlands and evaluation of the fifth generation, 5G, for wireless communication and cancer risks." That paper evaluated 5G evidence and singled out the nearby 26 gigahertz band as still needing study. 4. Limits: Specific absorption rate, power density, modulation or pulsing, and the numerical assay results are not in the record.